Results 221 to 230 of about 491,626 (323)

Alternative Splicing: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Alternative splicing (AS) expands proteomic diversity and functional complexity in eukaryotes, regulated by spliceosomal components, RNA elements, and epigenetic modifications. Dysregulated AS contributes to diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions, among others. Therapeutic interventions, such as antisense
Zhi‐Min Zhu   +5 more
wiley   +1 more source

Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study. [PDF]

open access: yesFront Pediatr
Ushida E   +12 more
europepmc   +1 more source

A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma

open access: diamond, 2016
Meng-Yuan Zhu   +8 more
openalex   +2 more sources

Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Early T‐cell precursor acute lymphoblastic leukemia (ETP‐ALL) was an aggressive subtype of T‐ALL with an extremely poor prognosis. We demonstrated that the V‐HAG regimen (venetoclax, homoharringtonine, cytarabine, and G‐CSF) was highly effective in refractory/relapsed patients.
Xiang Zhang   +20 more
wiley   +1 more source

Nanosensors in Leukemia Management: Pioneering Real‐Time Biomarker Detection for Precision Oncology

open access: yesNano Select, Volume 6, Issue 12, December 2025.
This review highlights pioneering nanosensors designed for real‐time leukemia biomarker detection, integrating advanced nanomaterials such as liposomes, polymeric nanoparticles and quantum dots. It examines electrochemical, optical and magnetic detection mechanisms, the applications across AML, ALL, CML, and CLL subtypes, and clinical translation ...
Hamed Soleimani Samarkhazan   +5 more
wiley   +1 more source

Mutation profiling in differential diagnosis between TdT‐positive high‐grade/large B‐cell lymphoma and B‐lymphoblastic leukaemia/lymphoma

open access: yesThe Journal of Pathology, Volume 267, Issue 4, Page 410-423, December 2025.
Abstract Terminal deoxynucleotidyl transferase (TdT) is occasionally expressed in large B‐cell lymphoma (LBCL), and this causes difficulty in differential diagnosis from B‐lymphoblastic leukaemia/lymphoma (B‐ALL/LBL). We reviewed 31 cases of TdT‐positive LBCL and B‐ALL/LBL, and their final diagnosis included 19 diffuse large/high‐grade BCLs with MYC ...
Maria‐Myrsini Tzioni   +27 more
wiley   +1 more source

Home - About - Disclaimer - Privacy